Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

23 та иш

Иш: Lipoproteinuria as an independent predictor of unfavorable outcome after intravenous thrombolysis in ischaemic stroke

  1. Сарлавҳасиз

    Бошқа3 иқтибос
    ABI

  2. Canadian Guidelines for Intravenous Thrombolytic Treatment in Acute Stroke: A Consensus Statement of The Canadian Stroke Consortium

    J W Norris, Alastair M. Buchan, Robert Côté +6

    Мақола19983 иқтибос
    ABI

  3. Reduced Estimated Glomerular Filtration Rate Is Associated with Stroke Outcome after Intravenous rt-PA: The Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA Registry

    Masaki Naganuma, Masatoshi Koga, Yoshiaki Shiokawa +11

    Мақола20103 иқтибос
    ABI

  4. Microalbuminuria and Endothelial Dysfunction: Emerging Targets for Primary Prevention of End-organ Damage

    Peter Ochodnický, Robert H. Henning, Richard P.E. van Dokkum +1

    Шарҳ мақола20063 иқтибос
    ABI

  5. Proteinuria and Stroke: A Meta-analysis of Cohort Studies

    Toshiharu Ninomiya, Vlado Perkovic, Christine Verdon +8

    Шарҳ мақола20083 иқтибос
    ABI

  6. Microalbuminuria: Risk factor and potential therapeutic target for stroke?

    Bruce Ovbiagele

    Шарҳ мақола20083 иқтибос
    ABI

  7. Prevalence of Chronic Kidney Disease in the United States

    Josef Coresh, Elizabeth Selvin, Lesley A. Stevens +5

    Мақола20073 иқтибос
    ABI

  8. Prediction of hemorrhagic transformation in acute ischaemic stroke by micro‐ and macroalbuminuria after intravenous thrombolysis

    Bang-Hoon Cho, Joon‐Tae Kim, Jason J. Chang +3

    Мақола20133 иқтибос
    ABI

  9. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan

    Chi Pang Wen, Ting Cheng, Min Kuang Tsai +8

    Мақола20083 иқтибос
    ABI

  10. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC‐Norfolk) population study

    Matthew F. Yuyun, K.‐T. Khaw, Robert Luben +4

    Мақола20043 иқтибос
    ABI

  11. Renal function and outcome among stroke patients treated with IV thrombolysis

    Philippe Lyrer, Felix Fluri, D. Gisler +3

    Мақола20083 иқтибос
    ABI

  12. Feasibility and Safety of Intravenous Thrombolysis in Multiethnic Asian Stroke Patients in Singapore

    Vijay K. Sharma, Georgios Tsivgoulis, June H. Tan +4

    Мақола20103 иқтибос
    ABI

  13. The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

    Keith A.A. Fox, Elliott M. Antman, Gilles Montalescot +7

    Мақола20073 иқтибос
    ABI

  14. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study

    Nils Wahlgren, Niaz Ahmed, Antoni Dávalos +12

    Мақола20073 иқтибос
    ABI

  15. The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes

    Botir T. Daminov, PhD, ScD, Sherzod Abdullaev

    Мақола20133 иқтибос
    ABI

  16. Tissue-plasminogen activator for acute ischaemic stroke

    Askiel Bruno

    Бошқа19972 иқтибос
    ABI

  17. Thrombogenic factors are related to urinary albumin excretion rate in Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetic patients

    Paul Knöbl, G. Schernthaner, Ch. Schnack +4

    Мақола19932 иқтибос
    ABI

  18. Chronic Kidney Disease and Clinical Outcome in Patients With Acute Stroke

    Gilad Yahalom, Roseline Schwartz, Yvonne Schwammenthal +5

    Мақола20092 иқтибос
    ABI

  19. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  20. Сарлавҳасиз

    Бошқа2 иқтибос
    ABI

  21. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа1 иқтибос
    ABI